1. Hem
  2. Products
  3. Elocta
  4. Indications for ELOCTA
Se-Elocta-0

For all ages1

ELOCTA can be used in patients of all ages, including PUPs, and in multiple clinical settings.1

Explore dosing guidance for different clinical settings below.

Prophylaxis1

For prophylaxis, the recommended dose is 50 IU/kg administered every 3–5 days. The dose may be adjusted based on individual response in the range of 25–65 IU/kg.

Prophylaxis chart

In some cases, especially in younger patients, shorter dosing intervals or higher doses may be necessary.

On-demand treatment1

The required dose is determined using the following formula:

Required units = body weight (kg) × desired FVIII rise (%) (IU/dL) × 0.5 (IU/kg per IU/dL). The amount to be administered and the frequency of administration should always be oriented to the clinical effectiveness in the individual case.

For the types of haemorrhagic events listed below, FVIII activity should not fall below the given plasma activity level (in % of normal or IU/dL) in the corresponding period.

Formula table

Adapted from the ELOCTA SmPC May 2021.

For surgery1

For the types of surgery listed below, FVIII activity should not fall below the given plasma activity level (in % of normal or IU/dL) in the corresponding period.

Surgery table

Adapted from the ELOCTA SmPC May 2021.

Provide comprehensive protection across multiple clinical settings with ELOCTA.1

Find out more

*In some patients and circumstances the dosing interval can be extended up to 36 hours.1
FVIII, factor VIII; IU, international unit; PUP, previously untreated patient.

1. ELOCTA SmPC 01/2021.

PP-18595
Other sites
expand_less